Table 1.
SYSTEM | SOURCE | ANTIGEN DEPENDENT OR INDEPENDENT | AMENABLE TO TRANSDUCTION | ANTIGEN PROCESSING | CLINICAL TRIALS | COMMENTS |
---|---|---|---|---|---|---|
Cellular | ||||||
K562 | Human erythroleukemia | Both | Yes | Yes | No | Transduced Fc receptors can bind αCD3 or HLA-Ig to allow antigen-specific or non-specific CD8+ T cell expansion Better CD8+ T cell proliferation when expressing 4-1BBL than αCD28 Has been prepared as GMP-compliant stock Might require HLA transduction for antigen presentation |
3T3 | Murine fibroblast | Both | Yes | Yes | No | Minimal evidence of xenoreactivity Requires HLA transduction for antigen presentation |
Insect | Drosophila Schneider S2 cell line | Both | Yes | No | Yes | Lysed at 37°C Exogenous antigen only Minimal evidence of xenoreactivity |
Acellular | ||||||
αCD3/αCD28 beads | Synthetic | Independent | No | No | Yes | Standardized manufacture Excellent control of delivered signals Better CD8+ T cell proliferation when 4-1BBL is substituted for αCD28 Can substitute or add costimulatory or inhibitory molecules |
HLA-Ig beads | Synthetic | Dependent | No | No | No | Excellent control of delivered signals Can substitute other HLA-Ig Exogenous antigen loading only |